Product image of Lemtrada- CH (Alemtuzumab) 12 mg/1.2ml Vials supplied by GNH India

Lemtrada- CH

Active Ingredient:
Alemtuzumab
Form:
Vials
Brand:
LEMTRADA
Origin:
Switzerland

Lemtrada- CH (Alemtuzumab Vials) 12 mg/1.2ml

Lemtrada-CH (Alemtuzumab) is a prescription medication supplied as 12 mg/1.2 ml vials for intravenous use. It is used in certain autoimmune conditions under medical supervision. Store between 2–8°C and protect from light. Always follow healthcare provider guidance.

Strength

12 mg/1.2ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

SANOFI-AVENTIS (SUISSE)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Lemtrada-CH (Alemtuzumab) is used to treat relapsing forms of multiple sclerosis and certain blood disorders. It works by targeting specific immune cells to reduce disease activity. Patients often ask what Lemtrada-CH is used for in managing chronic conditions. This therapy is typically reserved for cases where other treatments have not been effective.

Side Effects

  • Lemtrada-CH may cause flu-like symptoms such as fever, chills, or fatigue shortly after administration. Some patients experience headache or rash during treatment. These effects are generally temporary and monitored by healthcare professionals. Regular follow-up is advised to assess response and tolerability.

Precautions & Warnings

  • Lemtrada-CH requires careful handling and administration by trained healthcare providers. It should be stored refrigerated at 2–8°C and protected from light. Patients must report any signs of infection or unusual symptoms promptly. Avoid exposure to extreme temperatures and ensure proper disposal of vials.

Avoid Interactions

  • Lemtrada-CH may interact with medications that affect the immune system, such as corticosteroids or immunosuppressants. Alcohol and certain vaccines should be used with caution during treatment. Always inform your healthcare provider about all medications and supplements being taken. Live vaccines are generally avoided during therapy.

Frequently Asked Questions

Lemtrada-CH (Alemtuzumab) is used to treat relapsing forms of multiple sclerosis and certain blood disorders under medical supervision.

Lemtrada-CH is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects include flu-like symptoms, headache, and rash, which are usually temporary.

Lemtrada-CH requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Store Lemtrada-CH vials refrigerated between 2–8°C and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Alemtuzumab

Mabcampath 30 mg

Mabcampath 30 mg

30 MG SOLUTION
Lemtrada 12 mg

Lemtrada 12 mg

12 MG SOLUTION
Lemtrada

Lemtrada

12 mg/1.2ml Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT